Week 20: Closing Out 12.5mg
Four weeks at 12.5mg complete. The next titration window — the move to the maximum 15mg dose — opens at week 21. This is the week to look at the data and decide whether to take that step.
In SURMOUNT-1, the difference between 12.5mg and 15mg by trial endpoint was modest but real — roughly two to three percentage points of additional mean body weight reduction in the 15mg arm. For some users that difference is meaningful; for others, 12.5mg is already delivering everything they need and the extra is unnecessary.
The week-20 question is therefore practical rather than mechanical: is the trend at 12.5mg adequate for your remaining distance to goal, and is the side-effect profile tolerable? If both answers are yes, holding at 12.5mg is the simpler and often equally effective choice.
Appetite Suppression
Stable. Late-injection-week hunger creep is rare at this dose; if present, it can signal time for the step up.
Typical late-cycle loss. Five-month cumulative loss commonly lands between 17 and 20 percent of starting body weight.
Week 20 Timeline
The Week 20 Timeline
Day 134 (Injection 20)
Fourth 12.5mg Dose
Your final scheduled dose at 12.5mg before the next titration window opens. Inject as routine; nothing about this dose itself is different.
Days 136-138
Five-Month Review
Compile the four-month and five-month data side by side. The slope at 12.5mg tells you whether moving to 15mg adds value or simply adds side effect risk.
Day 140
Max-Dose Decision
Discuss with your prescriber: move to 15mg, hold at 12.5mg, or — if the trend is excellent — consider whether 12.5mg becomes your maintenance dose later.
Navigating Symptoms
The 15mg dose offers a small additional benefit on average. For users tracking well on 12.5mg, the extra side effect risk often outweighs the marginal gain. There is no requirement to climb.
A second labs check is worth doing this week if it has been a few months. A1C trends, lipid panel, basic metabolic panel, and liver enzymes all routinely improve on tirzepatide and serve as a quantitative companion to the scale.
What Users Report
“Five months, down 44 pounds, holding at 12.5mg. The trend is steady and 15mg felt unnecessary. I would rather slow down and protect muscle than chase the next dose.”
— Imani O.
“Moving to 15mg next week. I still have 30 pounds to lose and the weekly loss has slowed to a pound. Doctor and I agreed the bump is worth it for me.”
— Felipe S.
Looking ahead
Week 21 begins either 15mg or another cycle of 12.5mg, depending on the decision. Continue to the week 21 guide for what to expect from the maximum dose.